Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-011381
Filing Date
2023-03-31
Accepted
2023-03-31 16:12:28
Documents
22

Document Format Files

Seq Description Document Type Size
1 PRE 14A kpti-20230331.htm   iXBRL PRE 14A 4095649
2 GRAPHIC img94465779_0.jpg GRAPHIC 33329
3 GRAPHIC img94465779_1.jpg GRAPHIC 8774
4 GRAPHIC img94465779_2.jpg GRAPHIC 33329
5 GRAPHIC img94465779_3.jpg GRAPHIC 60747
6 GRAPHIC img94465779_4.jpg GRAPHIC 55738
7 GRAPHIC img94465779_5.jpg GRAPHIC 56403
8 GRAPHIC img94465779_6.jpg GRAPHIC 61284
9 GRAPHIC img94465779_7.jpg GRAPHIC 59353
  Complete submission text file 0000950170-23-011381.txt   6356679

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kpti-20230331_def.xml EX-101.DEF 5993
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kpti-20230331_lab.xml EX-101.LAB 13018
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kpti-20230331.xsd EX-101.SCH 5191
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kpti-20230331_pre.xml EX-101.PRE 7252
16 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20230331_htm.xml XML 444545
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36167 | Film No.: 23787768
SIC: 2834 Pharmaceutical Preparations